TNF and Miyoshi myopathy: To further evaluate EGF, TNF-α/NFκB and HBO1 pathway signaling within each HSC1–6 and MLP subset across patient/treatment/disease characteristics (allo-donor versus MM) and mobilization regimen, pathway expression scores were generated for each pathway (Extended Data Fig. 8 and Methods).